Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome

医学 氯吡格雷 替卡格雷 经皮冠状动脉介入治疗 急性冠脉综合征 内科学 狼牙棒 阿司匹林 传统PCI 心肌梗塞 危险系数 累积发病率 临床终点 心脏病学 队列 临床试验 置信区间
作者
Dandan Li,Yang Sun,Xiaoran Ye,Lanting Li,Yundai Chen,Dao Wen Wang
出处
期刊:Advances in Therapy [Adis, Springer Healthcare]
卷期号:39 (1): 754-766 被引量:6
标识
DOI:10.1007/s12325-021-01907-3
摘要

The objective of the present study was to evaluate the difference in net clinical benefit of clopidogrel plus aspirin compared with ticagrelor plus aspirin after 12 months in patients in mainland China with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with newer-generation drug-eluting stents (DESs).In this multicenter, retrospective, real-world study, the data were sourced from three databases: BRIC-ACS(I) study, COSTIC study, and 301 Hospital PCI patient database from January 2014 to October 2017. The primary endpoint of the study was net adverse clinical and cerebral events (NACCE) comprised of all-cause death, non-fatal myocardial infarction (MI), non-fatal stroke or Bleeding Academic Research Consortium (BARC) type ≥ 2 (excluding BARC type = 4) bleeding, whereas the secondary end point was evaluation of major adverse cardiovascular events (MACE) and BARC type ≥ 2 bleeding events.A total of 7862 ACS patients were included in the final analysis, of whom propensity score matching (PSM) analysis yielded 2165 patients in each cohort. After PSM analysis, cumulative incidence of NACCE was significantly lower with clopidogrel and aspirin than with ticagrelor and aspirin [117 (5.4%) vs. 180 (8.3%), P < 0.001] at 12 months. Effect estimates showed reduced risk of NACCE occurrence in patients treated with clopidogrel and aspirin [adjusted hazard ratio (aHR): 0.61, 95% CI 0.48-0.77, P < 0.001]. Incidence of bleeding was significantly lower in the clopidogrel cohort than in the ticagrelor cohort (aHR: 0.48, 95% CI 0.35-0.66, P < 0.001). Clopidogrel and aspirin therapy was comparable to ticagrelor and aspirin in reducing the incidence of MACE after PSM analysis.In Chinese ACS patients who underwent PCI with second-generation DESs, outpatient use of clopidogrel dual antiplatelet therapy (DAPT) was associated with reduction in NACCE and bleeding.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
3秒前
安静的雨兰的应助被刺刺果采纳,获得10
3秒前
Hang发布了新的文献求助10
4秒前
领导范儿的应助被turbo采纳,获得10
4秒前
ljl完成签到,获得积分10
4秒前
5秒前
ucjudgo完成签到,获得积分10
5秒前
大模型的应助被Sheep采纳,获得10
5秒前
赘婿的应助被文艺天玉采纳,获得10
5秒前
露露发布了新的文献求助10
5秒前
残月斜影完成签到,获得积分10
5秒前
6秒前
天天快乐的应助被苦瓜大王采纳,获得10
6秒前
清新的妖妖完成签到,获得积分10
7秒前
thyee发布了新的文献求助10
7秒前
rank发布了新的文献求助10
9秒前
FU完成签到,获得积分20
9秒前
小马过河发布了新的文献求助10
10秒前
科研通AI2S的应助被华东小可爱采纳,获得10
10秒前
shuyiWang发布了新的文献求助10
11秒前
星月发布了新的文献求助10
11秒前
h11发布了新的文献求助10
11秒前
好运伴我左右完成签到,获得积分20
11秒前
称心幼荷发布了新的文献求助10
11秒前
12秒前
情怀的应助被大方的香露采纳,获得10
12秒前
12秒前
我有一双AJ哇完成签到,获得积分10
12秒前
12秒前
13秒前
所所的应助被科研通管家采纳,获得10
13秒前
SciGPT的应助被科研通管家采纳,获得10
13秒前
13秒前
13秒前
JamesPei的应助被科研通管家采纳,获得10
13秒前
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163746
求助须知:如何正确求助?哪些是违规求助? 9557874
关于积分的说明 21742203
捐赠科研通 7754407
什么是DOI,文献DOI怎么找? 3428345
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472945